Syndax Pharmaceuticals

Happy Intern Appreciation Day! We are incredibly grateful for our talented team of interns who have brought innovation, unique perspectives, and enthusiasm to our team this summer. Thank you for all you do!   #InternAppreciationDay #WeFlyHigherTogether

Mark your calendars! Join us for a conference call & webcast on Thursday, August 1 at 4:30 p.m. ET to hear the Syndax management team discuss our 2Q24 financial results and provide a business update. Learn more: https://lnkd.in/gK42nnJn   A replay will be available after the call.  

Happy #IndependenceDay! Today and every day, we are grateful to those who fought and sacrificed to protect our freedoms.   We also extend our heartfelt appreciation to the Syndaxers, clinicians, investigators, and patients who make our aspiration to reimagine cancer care possible. Together, we can soar to new heights.   Wishing all a wonderful holiday weekend spent with loved ones!   #WeAreSyndax

Congratulations to the Spring 2024 cohort of our Leadership Development Program (LDP)! Your dedication to personal growth and professional development is truly commendable. At Syndax, we are committed to empowering our team members to unlock their highest potential and advance their careers. Together, we soar to new heights! #GrowWithSyndax #WeFlyHigherTogether #ProfessionalDevelopment

All of our employees play a critical role in developing and delivering new therapies for patients in need. Hear from Rachel Razzaghi, a member of our Commercial Team, as she shares the opportunities she’s had to make a difference at Syndax. We believe that each Syndaxer’s unique perspective can spark innovative solutions that create a lasting impact on the world. #SoarWithSyndax #Careers #ProfessionalDevelopment

Join us in reimagining how cancer is treated alongside teammates who empower you to do your best work. Take the first step towards making a difference by applying today: syndax.com/careers

Today, we honor Juneteenth, an important day in American history commemorating the end of slavery in the United States. This observance is not only a celebration of hopefulness, resilience and empowerment but also a time of reflection.   At Syndax, we maintain our steadfast commitment to fostering an environment where all employees can bring their most authentic selves to work. Today and every day, we take the opportunity to consider how we can all contribute to creating a more equitable society, take part in positive change and better support one another.    #WeFlyHigherTogether

We enjoyed presenting at the European Hematology Association (EHA) 2024 Congress, where we had the privilege of joining industry innovators who share our dedication to realizing a future in which people with #cancer live longer and better than ever before. #EHA2024 #HemOnc #Leukemia

#BreakingNews: Today, we presented updated positive data from the Phase 1/2 BEAT AML and AUGMENT-102 combination trials of revumenib with acute leukemia at the European Hematology Association (EHA) 2024 Congress.   These data underscore the potential for revumenib to serve as a meaningful combination agent with current standard of care therapies and continues to fuel our commitment to exploring its utility across multiple lines of treatment for patients with acute leukemia where treatment options are urgently needed. Learn more by reviewing our press release below: https://lnkd.in/gvGn7MjF

#HappeningSoon: Join members of Syndax management for a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference today at 8:40 a.m. ET. Learn how we’re advancing our mission to improve the lives of patients by tuning in below: https://lnkd.in/gMgq9Npt A replay will be available after the call.